- Home
- ANGO vs RAPP Comparison
ANGO vs RAPP Comparison
Compare ANGO & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- RAPP
- Stock Information
- Founded
- ANGO 1988
- RAPP 2022
- Country
- ANGO United States
- RAPP United States
- Employees
- ANGO N/A
- RAPP N/A
- Industry
- ANGO Medical/Dental Instruments
- RAPP
- Sector
- ANGO Health Care
- RAPP
- Exchange
- ANGO Nasdaq
- RAPP Nasdaq
- Market Cap
- ANGO 400.8M
- RAPP 439.4M
- IPO Year
- ANGO 2004
- RAPP 2024
- Fundamental
- Price
- ANGO $9.45
- RAPP $14.77
- Analyst Decision
- ANGO Strong Buy
- RAPP Strong Buy
- Analyst Count
- ANGO 3
- RAPP 3
- Target Price
- ANGO $19.00
- RAPP $33.67
- AVG Volume (30 Days)
- ANGO 364.4K
- RAPP 147.1K
- Earning Date
- ANGO 10-02-2025
- RAPP 08-07-2025
- Dividend Yield
- ANGO N/A
- RAPP N/A
- EPS Growth
- ANGO N/A
- RAPP N/A
- EPS
- ANGO N/A
- RAPP N/A
- Revenue
- ANGO $292,498,000.00
- RAPP N/A
- Revenue This Year
- ANGO $7.13
- RAPP N/A
- Revenue Next Year
- ANGO $6.28
- RAPP N/A
- P/E Ratio
- ANGO N/A
- RAPP N/A
- Revenue Growth
- ANGO N/A
- RAPP N/A
- 52 Week Low
- ANGO $5.83
- RAPP $6.43
- 52 Week High
- ANGO $13.50
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- ANGO 60.20
- RAPP 51.96
- Support Level
- ANGO $8.65
- RAPP $13.90
- Resistance Level
- ANGO $9.20
- RAPP $16.41
- Average True Range (ATR)
- ANGO 0.32
- RAPP 1.29
- MACD
- ANGO 0.11
- RAPP -0.12
- Stochastic Oscillator
- ANGO 90.08
- RAPP 41.22
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.